Wells Fargo is introducing two investment funds aside from their primary offerings.
In a recent development, Wells Fargo Asset Management (WFAM) has introduced two new funds to the European market: the Small Cap Innovation (ISIN: LU2065731478) and Global Small Cap Equity (LU2065732104) funds.
The Small Cap Innovation fund, managed by Michael Smith and Christopher Warner, aims to invest in companies that demonstrate strong innovation and have a solid fundamental base. The focus is on companies with competitive advantages and driving industry changes. At least two-thirds of the fund's portfolio will be invested in the U.S.
On the other hand, the Global Small Cap Equity fund, managed by WFAM's global equity team, including portfolio managers Jim Tringas and Bryant VanCronkhite, focuses on companies that are well-managed and have financial flexibility that is not fully appreciated by the market. The fund's portfolio consists of global small-cap stocks from the S&P Developed Small Cap index.
Both funds comply with the UCITS directive and are currently only available to institutional investors.
A confirmation email has been sent for the subscription. The email contains a button to activate the subscription. If the email is not found in the inbox, it may be in the spam folder. It is essential to click the email to activate the subscription.
Unfortunately, there are no publicly available details about specific institutions in the European Union that are currently investing in the Small Cap Innovation and Global Small Cap Equity funds.
Up to 10% of the Global Small Cap Equity fund's portfolio is allowed from emerging markets. The fund seeks companies with strong balance sheets and high free cash flows, which allows them to grow at an accelerated pace.
In summary, WFAM has introduced two new funds to the European market, the Small Cap Innovation and Global Small Cap Equity funds. These funds aim to invest in innovative companies and well-managed small-cap stocks, respectively. Interested institutional investors can subscribe to these funds by activating the confirmation email they receive. However, details about the current investors are not publicly available at this time.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant